Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30172765 | 0.94 | TRIM24 (0.39) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL8213764 | 0.78 | TRIM24 (0.44) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL29507615 | 0.77 | CRBN (0.48) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL3684453 | 0.77 | CRBN (0.48) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL28972213 | 0.73 | CRBN (0.61) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL29121518 | 0.73 | TRIM24 (0.52) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL29001767 | 0.72 | FKBP5 (0.33) | FKBP5CRBN | |
| Tetradecane SCHEMBL27674067 | 0.72 | ALOX5 (0.41) | FKBP5CRBN | |
| SCHEMBL31681207 | 0.70 | CRBN (0.64) | TRIM24TRIM33ALDH1A1FKBP5CRBN | |
| SCHEMBL29697528 | 0.69 | TRIM24 (0.61) | TRIM24TRIM33ALDH1A1FKBP5CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020023752-A1 | TASK SPECIFIC CHELATING IONIC LIQUIDS FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-01-30 | — | — | WO | disclosed |
| EP-3142767-A1 | SURFACE MODIFIED FILTER MEDIA | Hollingsworth & Vose Company (US) | 2017-03-22 | — | — | EP | disclosed |
| EP-3142774-A1 | PRE-COALESCING MULTI-LAYERED FILTER MEDIA | Hollingsworth & Vose Company (US) | 2017-03-22 | — | — | EP | disclosed |
| WO-2015175869-A1 | PRE-COALESCING MULTI-LAYERED FILTER MEDIA | HOLLINGSWORTH & VOSE COMPANY (US) | 2015-11-19 | — | — | WO | disclosed |
| WO-2015175877-A1 | SURFACE MODIFIED FILTER MEDIA | HOLLINGSWORTH & VOSE COMPANY (US) | 2015-11-19 | — | — | WO | disclosed |
| EP-2152102-A2 | COMPOSITIONS, ARTICLES AND METHODS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | Technion Research & Development Foundation Ltd. (IL) | 2010-02-17 | — | — | EP | disclosed |
| WO-2009149334-A2 | MATERIALS AND PROCESS FOR ENHANCING SELECTIVE SEPARATIONS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2008136000-A2 | COMPOSITIONS, ARTICLES AND METHODS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008136906-A1 | PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY | THE GENERAL HOSPITAL CORPORATION (US) | 2008-11-13 | — | — | WO | disclosed |
| EP-1648397-A4 | EX VIVO PROGENITOR AND STEM CELL EXPANSION FOR USE IN THE TREATMENT OF DISEASE OF ENDODERMALLY-DERIVED ORGANS | GAMIDA CELL LTD (IL) | 2008-05-21 | — | — | EP | disclosed |
| EP-1649007-A4 | METHODS FOR EX-VIVO EXPANDING STEM/PROGENITOR CELLS | GAMIDA CELL LTD (IL) | 2008-05-14 | — | — | EP | disclosed |
| WO-2006093891-A2 | PHOTOSENSITIZERS FOR TARGETED PHOTODYNAMIC THERAPY | THE GENERAL HOSPITAL CORPORATION (US) | 2006-09-08 | — | — | WO | disclosed |
| EP-1649007-A2 | METHODS FOR EX-VIVO EXPANDING STEM/PROGENITOR CELLS | Gamida Cell Ltd. (IL) | 2006-04-26 | — | — | EP | disclosed |
| EP-1648397-A2 | EX VIVO PROGENITOR AND STEM CELL EXPANSION FOR USE IN THE TREATMENT OF DISEASE OF ENDODERMALLY-DERIVED ORGANS | Gamida Cell Ltd. (IL) | 2006-04-26 | — | — | EP | disclosed |
| EP-1534820-A2 | EX-VIVO EXPANSION OF HEMATOPOIETIC STEM CELL POPULATIONS IN MONONUCLEAR CELL CULTURES | Gamida Cell Ltd. (IL) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005007799-A2 | METHODS FOR EX-VIVO EXPANDING STEM/PROGENITOR CELLS | GAMIDA-CELL LTD. (IL) | 2005-01-27 | — | — | WO | disclosed |
| WO-2005007073-A2 | EX VIVO PROGENITOR AND STEM CELL EXPANSION FOR USE IN THE TREATMENT OF DISEASE OF ENDODERMALLY-DERIVED ORGANS | GAMIDA-CELL LTD. (IL) | 2005-01-27 | — | — | WO | disclosed |
| WO-2004016731-A2 | EX-VIVO EXPANSION OF HEMATOPOIETIC STEM CELL POPULATIONS IN MONONUCLEAR CELL CULTURES | GAMIDA-CELL LTD. (IL) | 2004-02-26 | — | — | WO | disclosed |
| EP-0619813-A1 | LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1994-10-19 | — | — | EP | disclosed |
| WO-1993012096-A1 | LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1993-06-24 | — | — | WO | disclosed |